| Literature DB >> 34217150 |
Shama Perveen1, Muhammad Akram1, Asim Nasar2, Adeela Arshad-Ayaz3, Ayaz Naseem3.
Abstract
This study explores the mechanism for timely and equitable distribution of coronavirus disease 2019 (COVID-19) vaccination among the various communities in Pakistan. It examines the factors that support and/or impede peoples' access and response towards COVID-19 vaccination in Pakistan. The study uses a literature synthesis approach to examine and analyze the situation of the COVID-19 vaccination in Pakistan. The research results show "hesitancy" and "inequality" as two fundamental challenges that hinder the successful delivery of COVID-19 vaccination in Pakistan. People are reluctant to use vaccines due to conspiracy theories and religious beliefs. However, inequality, especially unequal accessibility to all social groups appears to be a more significant barrier to getting a vaccine. We argue that there is a need to mobilize community influence, social media, and mass media campaigns for public education on vaccination programs along with the engagement of religious leaders to endorse the vaccination for the masses. The area of this study is underdeveloped; thereby, future studies are recommended to investigate the possible way for equitable distribution of vaccines in multiple regions.Entities:
Keywords: COVID-19; Pakistan; hesitancy; inequality; vaccine
Mesh:
Substances:
Year: 2021 PMID: 34217150 PMCID: PMC8426931 DOI: 10.1002/jcop.22652
Source DB: PubMed Journal: J Community Psychol ISSN: 0090-4392
Details of vaccines approved or authorized to vaccinate people
| No | Name | Vaccine type | Primary developer | Country of origin | Authorized in Pakistan |
|---|---|---|---|---|---|
| 1 | Comirnaty (BNT162b2) | mRNA‐based vaccine | Pfizer, BioNTech; Fosun Pharma | Multinational | No |
| 2 | Moderna COVID‐19 Vaccine (mRNA‐1273) | mRNA‐based vaccine | Moderna, BARDA, NIAID | US | No |
| 3 | COVID‐19 Vaccine AstraZeneca (AZD1222); also known as Vaxzevria and Covishield | Adenovirus vaccine | BARDA, OWS | UK | Yes |
| 4 | Sputnik V | Recombinant adenovirus vaccine (rAd26 and rAd5) | Gamaleya Research Institute, Acellena Contract Drug Research, and Development | Russia | Yes |
| 5 | COVID‐19 Vaccine Janssen (JNJ‐78436735; Ad26.COV2.S) | Non‐replicating viral vector | Janssen Vaccines (Johnson & Johnson) | The Netherlands, US | No |
| 6 | CoronaVac | Inactivated vaccine (formalin with alum adjuvant) | Sinovac | China | Yes |
| 7 | BBIBP‐CorV | Inactivated vaccine | Beijing Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) | China | Yes |
| 8 | EpiVacCorona | Peptide vaccine | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology | Russia | No |
| 9 | Convidicea (Ad5‐nCoV) | Recombinant vaccine (adenovirus type 5 vector) | CanSino Biologics | China | Yes |
| 10 | Covaxin (BBV152) | Inactivated vaccine | Bharat Biotech, ICMR | India | No |
| 11 | WIBP‐CorV | Inactivated vaccine | Wuhan Institute of Biological Products; China National Pharmaceutical Group (Sinopharm) | China | No |
| 12 | CoviVac | Inactivated vaccine | Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products | Russia | No |
| 13 | ZF2001 | Recombinant vaccine | Anhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of Sciences | China, Uzbekistan | No |
Abbreviation: COVID‐19, coronavirus disease 2019.
Source: (Craven, 2021).
Figure 1COVID‐19 vaccine doses administered per 100 people in the world. Source: https://ourworldindata.org/coronavirus‐as of May 22, 2021. COVID‐19, coronavirus disease 2019
Figure 2COVID‐19 situation in Pakistan as of May 22, 2021. Source: Government of Pakistan, Retrieved from https://COVID.gov.pk/stats/pakistan. COVID‐19, coronavirus disease 2019
Figure 3COVID‐19 vaccine doses administered per 100 people in and around Pakistan. Source: https://ourworldindata.org/coronavirus‐ as of May 22, 2021. COVID‐19, coronavirus disease 2019
Summary of selected papers from research database
| No | Authors | Title | Year published |
|---|---|---|---|
| 1 | Mehmood, K; Bao, YS; Petropoulos, GP; Abbas, R; Abrar, MM; Saifullah; Mustafa, A; Soban, A; Saud, S; Ahmad, M; Hussain, I; Fahad, S | Investigating connections between COVID‐19 pandemic, air pollution, and community interventions for Pakistan employing geoinformation technologies |
|
| 2 | Khan, MT; Ali, S; Khan, AS; Muhammad, N; Khalil, F; Ishfaq, M; Irfan, M; Al‐Sehemi, AG; Muhammad, S; Malik, A; Khan, TA; Wei, DQ | SARS‐CoV‐2 genome from the Khyber Pakhtunkhwa Province of Pakistan |
|
| 3 | Singh, J; Malik, D; Raina, A | Immuno‐informatics approach for B‐cell and T‐cell epitope‐based peptide vaccine design against novel COVID‐19 virus |
|
| 4 | Oud, MAA; Ali, A; Alrabaiah, H; Ullah, S; Khan, MA; Islam, S | A fractional order mathematical model for COVID‐19 dynamics with quarantine, isolation, and environmental viral load |
|
| 5 | Shahzad, F; Du, JG; Khan, I; Ahmad, Z; Shahbaz, M | Untying the precise impact of COVID‐19 policy on social distancing behavior |
|
| 6 | Qiang, XL; Aamir, M; Naeem, M; Ali, S; Aslam, A; Shao, ZH | Analysis and forecasting COVID‐19 outbreak in Pakistan using decomposition and Ensemble model |
|
| 7 | Khan, A; Bibi, A; Khan, KS; Butt, AR; Alvi, HA; Naqvi, AZ; Mushtaq, S; Khan, YH; Ahmad, N | Routine pediatric vaccination in Pakistan during COVID‐19: How can healthcare professionals help? |
|
| 8 | Kazi, AM; Qazi, SA; Khawaja, S; Ahsan, N; Ahmed, RM; Sameen, F; Mughal, MAK; Saqib, M; Ali, S; Kaleemuddin, H; Rauf, Y; Raza, M; Jamal, S; Abbasi, M; Stergioulas, LK | An artificial intelligence‐based, personalized Smartphone App to improve childhood immunization coverage and timelines among children in Pakistan: Protocol for a randomized controlled trial |
|
| 9 | Chandir, S; Siddiqi, DA; Mehmood, M; Setayesh, H; Siddique, M; Mirza, A; Soundardjee, R; Dharma, VK; Shah, MT; Abdullah, S; Akhter, MA; Khan, AA; Khan, AJ | Impact of COVID‐19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data |
|
| 10 | Naik, PA; Yavuz, M; Qureshi, S; Zu, J; Townley, S | Modeling and analysis of COVID‐19 epidemics with treatment in fractional derivatives using real data from Pakistan |
|
| 11 | Ullah, S; Khan, MA | Modeling the impact of non‐pharmaceutical interventions on the dynamics of novel coronavirus with optimal control analysis with a case study |
|
| 12 | Kakakhel, MA; Wu, F; Khan, TA; Feng, H; Hassan, Z; Anwar, Z; Faisal, S; Ali, I; Wang, W | The first two months epidimiological study of COVID‐19, related public health preparedness, and response to the ongoing epidemic in Pakistan |
|
| 13 | Yousaf, M; Zahir, S; Riaz, M; Hussain, SM; Shah, K | Statistical analysis of forecasting COVID‐19 for upcoming month in Pakistan |
|
| 14 | Anjum, FR; Anam, S; Rahman, SU | Novel coronavirus disease 2019 (COVID‐19): new challenges and new responsibilities in developing countries |
|
| 15 | Zubair, K; Luqman, M; Ijaz, F; Hafeez, F; Aftab, RK | Practices of general public towards personal protective measures during the coronavirus pandemic |
|
| 16 | Iqbal, Z; Aslam, MZ; Aslam, T; Ashraf, R; Kashif, M; Nasir, H | Persuasive power concerning COVID‐19 employed by premier Imran Khan: A socio‐political discourse analysis |
|
| 17 | Abbas, Q., Mangrio, F. and Kumar, S. | Myths, beliefs, and conspiracies about COVID‐19 vaccines in Sindh, Pakistan: An online cross‐sectional survey |
|
| 18 | Abid, K., Bari, Y. A., Younas, M., Tahir Javaid, S., & Imran, A. | Progress of COVID‐19 epidemic in Pakistan |
|
| 19 | Farooq, F., Khan, J., and Khan, M. U. G. | Effect of lockdown on the spread of COVID‐19 in Pakistan |
|
| 20 | Haqqi, A., Awan, U. A., Ali, M., Saqib, M. A. N., Ahmed, H., & Afzal, M. S. | COVID‐19 and dengue virus coepidemics in Pakistan: A dangerous combination for an overburdened healthcare system |
|
| 21 | Khalid, A. and Ali, S. | COVID‐19 and its challenges for the healthcare system in Pakistan |
|
| 22 | Khan, Y. H., Mallhi, T. H., Alotaibi, N. H., Alzarea, A. I., Alanazi, A. S., Tanveer, N., & Hashmi, F. K. | Threat of COVID‐19 vaccine hesitancy in Pakistan: The need for measures to neutralize misleading narratives |
|
| 23 | Khattak, F. A., Rehman, K., Shahzad, M., Arif, N., Ullah, N., Kibria, Z., Arshad, M., Afaq, S., Ibrahim, A. K., & ul Haq, Z. | Prevalence of parental refusal rate and its associated factors in routine immunization by using WHO Vaccine hesitancy tool: A cross‐sectional study at district Bannu, KP, Pakistan |
|
| 24 | Saqlain M, Munir MM, Rehman SU, Gulzar A, Naz S, Ahmed Z, Tahir AH, Mashhood M. | Knowledge, attitude, practice and perceived barriers among healthcare workers regarding COVID‐19: A cross‐sectional survey from Pakistan |
|
| 25 | Shoukat, A. and Jafar, M. | Scarce resources and careless citizenry: Effects of COVID‐19 in Pakistan. International Journal of Innovation, Creativity and Change, Special Edition: COVID‐19 Life Beyond |
|
| 26 | Umair, M., Ikram, A., Salman, M., Alam, M. M., Badar, N., Rehman, Z., Tamim, S., Khurshid, A., Ahad, A., Ahmad, H., & Ullah, S. | Importation of SARS‐CoV‐2 variant B. 1.1. 7 in Pakistan |
|
| 27 | Zakar, R., Yousaf, F., Zakar, M., & Fischer, F. | Socio‐cultural challenges in the implementation of COVID‐19 public health measures: Results from a qualitative study in Punjab, Pakistan |
|
Thematic analysis based on the literature synthesis
| Theme | Sub‐themes | Categories | Sub‐categories |
|---|---|---|---|
| The situation with respect to COVID‐19 vaccination in Pakistan | COVID‐19 vaccine hesitancy | Conspiracy theories |
Fake news about vaccine Misinformation about vaccine Lack of awareness on public health education Potential side effects |
| Religious beliefs |
Forbidden by religion ( Infidel vaccine Religious sect “Shia” virus Western‐made vaccine | ||
| COVID‐19 vaccine inequality | Policy implications |
Lack of policy for public and private health center | |
| Accessibility |
Socio‐political influence to get the vaccine Inability to buy the vaccine at private health centers |
Abbreviation: COVID‐19, coronavirus disease 2019.
Figure 4Some Tweets of Pakistani journalists on Minister's family being vaccinated. Source: www.dawn.com/news/1615465